Charming Medical Limited
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| – | +70.4% | +3.4% | -22.7% | |
| – | +3.2% | -2.9% | -11.9% | |
| – | +162.0% | +6.8% | -28.0% | |
| – | +49.5% | -11.6% | +103.7% | |
| – | +44.2% | -3.9% | +67.6% | |
| – | – | +37.7% | -90.7% | |
| – | +28.6% | -19.9% | -24.3% | |
| – | – | +43.0% | -90.7% | |
| – | – | +29.9% | – | |
| – | – | +54.2% | -101.9% | |
| – | – | +21.0% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.